MONISTAT COMPLETE CARE CHAFING RELIEF- dimethicone gel 
Insight Pharmaceuticals LLC

----------

Monistat Chafing Gel

Monistat Care Chafing Relief Powder Gel®

Drug Facts

Active ingredient

Dimethicone 1.2%

Purpose

Skin Protectant

Use

Warnings

For external use only.

Do not use on

  • deep or puncture wounds
  • animal bites
  • serious burns

When using this product

do not get into eyes.

Stop use and ask a doctor if

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

Keep out of reach of children.

If swallowed get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Apply as needed.

Other information

Store at 20˚-25˚C (68˚-77˚F)

Inactive ingredients

cyclomethicone, dimethicone, dimethicone/vinyl dimethicone crosspolymer, silica dimethyl silylate, vinyl dimethicone/methicone silsesquioxane crosspolymer 

Questions?

1-877-666-4782 Monistat.com

PRINCIPAL DISPLAY PANEL

MONISTAT
Care®
Chafing Relief Powder Gel®
DIMETHICONE /SKIN PROTECTANT
NET WT/ Peso Neto 1.5 oz (42g)

MONISTAT
Care®
Chafing Relief Powder Gel®
DIMETHICONE /SKIN PROTECTANT
NET WT/ Peso Neto 1.5 oz (42g)

MONISTAT COMPLETE CARE CHAFING RELIEF 
dimethicone gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63736-031
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE1.2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
SILICA DIMETHYL SILYLATE (UNII: EU2PSP0G0W)  
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63736-031-011 in 1 CARTON11/15/2013
142 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01611/15/2013
Labeler - Insight Pharmaceuticals LLC (055665422)

Revised: 4/2024
Document Id: 7298c9c8-609a-4f1e-967b-faf2d183aa77
Set id: 07d7c883-1fa3-4786-905c-a1fab649765e
Version: 5
Effective Time: 20240419
 
Insight Pharmaceuticals LLC